Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults (NCT07065721)
CAPAZ-2D: Continuous Glucose Monitoring to Augment and Personalize Self-Management of Type 2 Diabetes in Hispanic/Latinx Young Adults
🩺 Plain-English Summary (8th-Grade Level)
Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (3 items).
Location: Scripps Health — San Diego, California
Age range: 18 Years to 45 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- severe mental illness (e.g., psychosis, suicidal ideation);
- pregnancy or \<6 months postpartum
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Scripps Health — San Diego, California
📞 Contact the Study Coordinator
Phone: (619) 594-2132
Email: jlmccurley@sdsu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type 2 Diabetes Mellitus (T2DM)
- CGM for Management of Type 2 Diabetes in Pregnancy — Birmingham, Alabama
- Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations — Greenfield, Massachusetts
- A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Birmingham, Alabama
- Low-Dose Pioglitazone in Patients With NASH (AIM 2) — Gainesville, Florida
- A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus — Chula Vista, California
- BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes — Mexico City, Cuauhtémoc
Explore by condition: All Type 2 Diabetes Mellitus (T2DM) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.